Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of High Dose Proton Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Prospective Phase II Trial

NCT02571946 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02571946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02571946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of High Dose Proton Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: Prospective Phase II Trial
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2015
Completion date
September 30, 2021
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver neoplasm, portal vein tumor thrombosis, proton therapy